FDA Inspection 1193154 — Cliantha Research
The FDA completed an inspection of Cliantha Research on Nov 10, 2022 in Mississauga. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 10, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Mississauga (Canada)
Additional details
Clinical BA/BE